Search

Clear all

Refine your search

138 results found

Pharma Law News logo
GTDT Pharma Law News delivers a mix of news, features and interviews, with insight from leading pharmaceutical lawyers, in-house counsel and…
Article

Pharma Law News | Global | 13 Nov 2018

Ropes & Gray hires from Johnson & Johnson in Shanghai

Ropes & Gray has announced that Johnson & Johnson counsel Eric Wu is to re-join its Shanghai office as a life sciences partner.
Article

Pharma Law News | Global | 13 Nov 2018

China mulls new clinical trials rules

China has issued clinical study guidelines for drugs treating bipolar disorder and schizophrenia.
Article

Pharma Law News | Global | 13 Nov 2018

McCarter & English adds two patent partners in Boston

US McCarter & English has recruited IP lawyers John Gutkoski and Jonathan Lovely as partners in its Boston office.
Article

Pharma Law News | Global | 13 Nov 2018

EMA issues new guidance on paediatric pharmacovigilance practice

The European Medicines Agency has released new guidelines for good pharmacovigilance practice (GVP) in paediatric populations.
Article

Pharma Law News | Global | 13 Nov 2018

The PLN Round-up (13 November)

News in brief from around the world… MPs have written to US pharma company Vertex to demand information on its negotiations with the NHS, China has announced new vaccine regulations and a US appeals court has affirmed Fresenius’s Diprivan patent loss.
Article

Pharma Law News | China | 13 Nov 2018

China mulls new clinical trials rules

China has issued clinical study guidelines for drugs treating bipolar disorder and schizophrenia. While not official legislation, the measures…
Article

Pharma Law News | Global | 6 Nov 2018

Corporate Counsel Q&A – Iain Ward, GW Pharma

On 1 November, cannabis-based epilepsy treatment Epidiolex went on sale throughout the US, having become the first drug incorporating non-synthetic cannabidiol to win FDA approval over the summer. In our latest in-house Q&A, PLN caught up with Epidiolex manufacturer GW Pharmaceutical’s general counsel Iain Ward.
Article

Pharma Law News | Global | 6 Nov 2018

ECJ finds medical device products ineligible for supplementary protection certificates

Medicinal products and medical devices are “mutually exclusive” concepts under EU law, making it impossible for devices and their constituent substances to qualify for supplementary protection certificates (SPCs) to extend their patent terms, the European Court of Justice has said.
Article

Pharma Law News | Global | 6 Nov 2018

Four A&O alumni follow Dagg to Kirkland

Four former members of the life sciences IP team at Allen & Overy have joined the firm’s ex-head of IP litigation Nicola Dagg at Kirkland & Ellis in London.
Article

Pharma Law News | Global | 6 Nov 2018

Davis Polk and McCann Fitzgerald advise Novo Nordisk on Strongbridge drug buy

Lawyers from Davis Polk & Wardwell in the US and McCann Fitzgerald in Ireland have advised Danish pharma company Novo Nordisk on its purchase of the US and Canadian rights to Strongbridge Biopharma’s hormone deficiency drug Macrilen.
Previous page 1 2 3 ...